BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32513446)

  • 21. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    Zhang HW; Zhong XM; Zhang ZH; Pang HW
    BMC Cancer; 2023 Apr; 23(1):385. PubMed ID: 37106444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary results of conformal computed tomography (CT)-based intracavitary brachytherapy (ICBT) for locally advanced cervical cancer: a single institution's experience.
    Tharavichitkul E; Mayurasakorn S; Lorvidhaya V; Sukthomya V; Wanwilairat S; Lookaew S; Pukanhaphan N; Chitapanarux I; Galalae R
    J Radiat Res; 2011; 52(5):634-40. PubMed ID: 21952319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer.
    Shi D; He MY; Zhao ZP; Wu N; Zhao HF; Xu ZJ; Cheng GH
    Asian Pac J Cancer Prev; 2015; 16(9):3945-9. PubMed ID: 25987066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
    Siavashpour Z; Aghamiri MR; Jaberi R; ZareAkha N; Manshadi HRD; Kirisits C; Sedaghat M
    J Appl Clin Med Phys; 2016 May; 17(3):5-13. PubMed ID: 27167253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimension anatomy-based planning optimization for high dose rate vaginal vault brachytherapy.
    Bahadur YA; Hassouna AH; Constantinescu CT; Naga AF; Ghasal NM; Elsayed ME
    Saudi Med J; 2012 Jun; 33(6):640-7. PubMed ID: 22729119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
    Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
    Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
    J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
    Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
    Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using the computed tomography in comparison to the orthogonal radiography based treatment planning in high dose rate (HDR) brachytherapy in cervical uteri cancer patients; a single institution feasibility study.
    Bahadur YA; El-Sayed ME; El-Taher ZH; Zaza KO; Moftah BA; Hassouna AH; Ghassal NM
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):1-9. PubMed ID: 19847276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.
    Li N; Carmona R; Sirak I; Kasaova L; Followill D; Michalski J; Bosch W; Straube W; Mell LK; Moore KL
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):164-172. PubMed ID: 27979445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectum and bladder spacing in cervical cancer brachytherapy using a novel injectable hydrogel compound.
    Damato AL; Kassick M; Viswanathan AN
    Brachytherapy; 2017; 16(5):949-955. PubMed ID: 28619385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
    Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
    J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
    Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
    Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
    Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.